Advanced glycation end-products: a review

被引:0
|
作者
R. Singh
A. Barden
T. Mori
L. Beilin
机构
[1] Dept of Medicine,
[2] University of Western Australia and West Australian Heart Research Institute,undefined
[3] Perth,undefined
[4] Australia,undefined
来源
Diabetologia | 2001年 / 44卷
关键词
Keywords Advanced glycated end-products; diabetes mellitus; microvascular disease; carbonyl stress; aminoguanidine.;
D O I
暂无
中图分类号
学科分类号
摘要
Advanced glycation end-products are a complex and heterogeneous group of compounds that have been implicated in diabetes related complications. At present it is not known if they are the cause or the consequence of the complications observed. We discuss the chemistry of advanced glycated end-product formation and their patho-biochemistry particularly in relation to the diabetic microvascular complications of retinopathy, neuropathy and nephropathy as well as their role in the accelerated vasculopathy observed in diabetes. The concept of carbonyl stress as a cause for advanced glycated end-product toxicity is mentioned. We discuss alterations in the concentrations of advanced glycated end-products in the body, particularly in relation to changes occuring with age, diabetes and its complications such as nephropathy. Problems relating to current methods of advanced glycated end-product detection and measurement are highlighted including the lack of a universally established method of detection or unit of measurement. Agents used for the treatment of advanced glycated end-product accumulation are reviewed, with an emphasis on the results of the recent phase III trials using aminoguanidine and diabetes related complications. [Diabetologia (2001) 44: 129–146]
引用
收藏
页码:129 / 146
页数:17
相关论文
共 50 条
  • [21] Physiological and pathophysiological importance of advanced glycation end-products
    Simm, A.
    Ruhs, S.
    Nass, N.
    Bartling, B.
    Broemme, H. J.
    Leuner, B.
    Somoza, V.
    Friess, U.
    Silber, R. E.
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 65 : S11 - S11
  • [22] Clinical/Translational Aspects of Advanced Glycation End-Products
    Zeng, Chang
    Li, Yuanyuan
    Ma, Jingzhi
    Niu, Lina
    Tay, Franklin R.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (12): : 959 - 973
  • [23] The health risks of dietary advanced glycation end-products
    Pischetsrieder, Monika
    Buetler, Timo
    MOLECULAR NUTRITION & FOOD RESEARCH, 2007, 51 (09) : 1071 - 1073
  • [24] Advanced glycation end-products in sickle cell anaemia
    Somjee, SS
    Warrier, RP
    Thomson, JL
    Ory-Ascani, J
    Hempe, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (01) : 112 - 118
  • [25] Receptor for advanced glycation end-products in neurodegenerative diseases
    Juranek, Judyta
    Ray, Rashmi
    Banach, Marta
    Rai, Vivek
    REVIEWS IN THE NEUROSCIENCES, 2015, 26 (06) : 691 - 698
  • [26] Pathophysiology of advanced glycation end-products in renal failure
    Miyata, T
    Iida, Y
    Horie, K
    Cai, Z
    Sugiyama, S
    Maeda, K
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 27 - 30
  • [27] Advanced glycation end-products in corneas of patients with keratoconus
    Jens Dawczynski
    Sibylle Franke
    Marcus Blum
    Michael Kasper
    Günter Stein
    Jürgen Strobel
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2002, 240 : 296 - 301
  • [28] ADVANCED GLYCATION END-PRODUCTS IN PATHOLOGY OF THE TRANSPLANTED HEART
    Zakliczynski, Michael
    Nozynski, Jerzy
    Konecka-Mrowka, Dominika
    Zembala, Marian
    TRANSPLANT INTERNATIONAL, 2009, 22 : 26 - 26
  • [29] Advanced glycation end-products and arterial stiffness in hypertension
    McNulty, Marie
    Mahmud, Azra
    Feely, John
    AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (03) : 242 - 247
  • [30] RENAL AGEING AND GLYCATION: IMPLICATION OF RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS
    Tessier, Thibault
    Quersin, Valentine
    Gnemmi, Viviane
    Delguste, Florian
    Daroux, Maite
    Tessier, Frederic
    Boulanger, Eric
    Frimat, Marie
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32